Comparison of arterial versus venous phases enhancement in radiation therapy planning for patients with pancreatic cancer: the PANCRINJ study

Author:

Zaidi Fabien1,Calame Paul2,Chevalier Cédric1,Henriques Julie3,Vernerey Dewi3,Vuitton Lucine4,Heyd Bruno5,Borg Christophe6,Boustani Jihane1

Affiliation:

1. Department of Radiotherapy, University of Bourgogne Franche-Comté, CHU Besançon, 25030 Besançon

2. Department of Radiology, University of Bourgogne Franche-Comté, CHU Besançon, 25030 Besançon

3. Methodology and Quality of Life Unit in Oncology, CHU Besançon, 25030 Besançon

4. Department of Gastroenteroly, University of Bourgogne Franche-Comté, CHU Besançon, 25030 Besançon

5. Department of Digestive surgery, University of Bourgogne Franche-Comté, CHU Besançon, 25030 Besançon

6. Department of Oncology, University of Bourgogne Franche-Comté, CHU Besançon, 25030 Besançon

Abstract

Abstract Background:The planification of radiation therapy (RT) for pancreatic cancer (PC) requires a dosimetric computed tomography (CT) scan to define the gross tumor volume (GTV). The main objective of this study was to compare the inter-observer variability in RT planning between the arterial and the venous phases following intravenous contrast. Methods: PANCRINJ was a prospective monocentric study that included twenty patients with non-metastatic PC. Patients underwent a pre-therapeutic CT scan at the arterial and venous phases. The delineation of the GTV was performed by one radiologist (gold standard) and two senior radiation oncologists (operators). The primary objective was to compare the Jaccard conformity index (JCI) for the GTVs computed between the gs and the operators between the arterial and the venous phases with a Wilcoxon signed rank test for paired samples. The secondary endpoints were the geographical miss index (GMI), the kappa index, the intra-operator variability, and the dose-volume histograms between the arterial and venous phases. Results:The median JCI for the arterial and venous phases were 0.50 (range, 0.17-0.64) and 0.41 (range, 0.23-0.61) (p=0.10) respectively. The median gsGTV was statistically significantly smaller compared to the operators at the arterial (p<0.0001) and venous phases (p<0.001), respectively. The GMI were low with few tumors missed for all patients with a median GMI of 0.07 (range, 0-0.79) and 0.05 (range, 0-0.39) at the arterial and venous phases, respectively (p=0.15). There was a moderate agreement between the radiation oncologists with a median kappa index of 0.52 (range 0.38-0.57) on the arterial phase, and 0.52 (range 0.36-0.57) on the venous phase (p=0.08). The intra-observer variability for GTV delineation was lower at the venous phase than at the arterial phase for the two operators. There was no significant difference between the arterial and the venous phases regarding the dose-volume histogram for the operators. Conclusions: Our results showed inter- and intra-observer variability in delineating GTV for PC without significant differences between the arterial and the venous phases. The use of both phases should be encouraged. Our findings suggest the need to provide training for radiation oncologists in pancreatic imaging and to collaborate within a multidisciplinary team.

Publisher

Research Square Platform LLC

Reference32 articles.

1. 13-Pancreas fact sheet. In: Global Cancer Observatory 2020. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/13-Pancreas-fact-sheet.pdf. Accessed 11 Aug 2022.

2. SPF. Estimations nationales de l’incidence et de la mortalité par cancer en France métropolitaine entre 1990 et 2018 - Tumeurs solides: Étude à partir des registres des cancers du réseau Francim. In Sante Publique France. Available from: https://www.santepubliquefrance.fr/import/estimations-nationales-de-l-incidence-et-de-la-mortalite-par-cancer-en-france-metropolitaine-entre-1990-et-2018-tumeurs-solides-etude-a-partir. Accessed 11 Aug 2022.

3. Pancreatic adenocarcinoma;Ryan DP;N Engl J Med,2014

4. Pancreatic Adenocarcinoma version 2.2023. In NCCN, National Comprehensive Cancer Network. ; Available from: https://www.nccn.org/guidelines/guidelines-detail. Accessed 27 Aug 2023.

5. Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib: The LAP07 Randomized Clinical Trial;Hammel P;JAMA,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3